These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 8878761

  • 1. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC, Fisher RA, Cohen DS, Tawes JW, Grimes MM.
    J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
    [Abstract] [Full Text] [Related]

  • 2. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR, Ventura HO, Chambers RB, Ramireddy K, Smart FW, Stapleton DD.
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [Abstract] [Full Text] [Related]

  • 3. Cardiac allograft tolerance induction with limited immunosuppression.
    Cohen DS, Fisher RA, Tarry WC, Tawes JW.
    J Surg Res; 1996 Mar; 61(2):355-60. PubMed ID: 8656608
    [Abstract] [Full Text] [Related]

  • 4. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    Vassalli G, Kaski JC, Tousoulis D, Kiowski W, Turina M, Follath F, Gallino A.
    J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
    [Abstract] [Full Text] [Related]

  • 5. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
    Murphy GJ, Bicknell GR, Nicholson ML.
    Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
    [Abstract] [Full Text] [Related]

  • 6. Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats.
    Hisatomi K, Isomura T, Ohashi M, Tamehiro K, Sato T, Tayama E, Ohishi K, Kohjiro M.
    J Heart Lung Transplant; 1995 May; 14(1 Pt 1):113-8. PubMed ID: 7537098
    [Abstract] [Full Text] [Related]

  • 7. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C, Heemann U, Azuma H, Tilney NL.
    Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
    [No Abstract] [Full Text] [Related]

  • 8. Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.
    Lijkwan MA, Cooke DT, Martens JM, Kown MH, Murata S, Peterson SH, Hoyt EG, Robbins RC.
    J Heart Lung Transplant; 2005 Apr; 24(4):439-45. PubMed ID: 15797746
    [Abstract] [Full Text] [Related]

  • 9. The influence of antigen-dependent and antigen-independent factors on the development of graft vasculopathy in a fully allogeneic cardiac allograft model in the rat.
    Fiedel S, Bayer J, Schaub M, Heidt MC, Grebe M, Tillmanns H, Stadlbauer TH.
    Transplant Proc; 2009 Apr; 41(6):2625-7. PubMed ID: 19715988
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y, Tang XD, Zhou PJ.
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nutritional immunomodulation enhances cardiac allograft survival in rats treated with donor-specific transfusion and cyclosporine.
    Levy AE, Alexander JW.
    Transplantation; 1995 Oct 27; 60(8):812-5. PubMed ID: 7482740
    [Abstract] [Full Text] [Related]

  • 15. Use of rapamycin slows progression of cardiac transplantation vasculopathy.
    Mancini D, Pinney S, Burkhoff D, LaManca J, Itescu S, Burke E, Edwards N, Oz M, Marks AR.
    Circulation; 2003 Jul 08; 108(1):48-53. PubMed ID: 12742978
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
    Moien-Afshari F, Choy JC, McManus BM, Laher I.
    J Heart Lung Transplant; 2004 Feb 08; 23(2):193-203. PubMed ID: 14761767
    [Abstract] [Full Text] [Related]

  • 20. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
    Koskinen PK, Lemström KB, Häyry PJ.
    Am J Pathol; 1995 Apr 08; 146(4):972-80. PubMed ID: 7536397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.